🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#MyoStrain #Oncology #Cardiology #CardioOnc #WorldCancerDay

#MyoStrain enables physicians to detect heart dysfunction early and treat patients before heart damage occurs. The MyoHealth™ Score represents the percentage of a patient's heart that is functioning normally. #HeartMonth #Cardiology American Heart Association The Heart Truth

#MyoStrain enables physicians to detect heart dysfunction early and treat patients before damage occurs. Learn More: bit.ly/3Es6uCs American Heart Association The Heart Truth #Cardiology #HeartMonth #HeartHealth #HeartDisease #OurHearts

#MyoStrain helps physicians monitor congenital heart disease. #CHDAwareness #CHD #PCHD #Cardiology #CardioTwitter #HeartMonth Connecticut Children's Olga H Toro Salazar Anu Dodeja, MD, FACC Learn more: getmyostrain.com

Studies show that COVID-19 can have lasting cardiovascular effects. MyoStrain enables physicians to monitor long COVID patients’ hearts. #MyoStrain #COVID #LongCovid #ACC #CardioTwitter #HeartMonth #OurHearts Source: acc.org/About-ACC/Pres…

Vithas Malaga launches the first cardiology program in Spain.

Follow Myocardial Solutions at #GlobalCardioOncologySummit2023 this September in Madrid!

MyoStrain offers a game-changing solution with its rapid and accurate assessment. Learn more about how this technology is helping mitigate false negative and positive test results: myocardialsolutions.com/applications/e…

Elevate your clinical practice with MyoStrain and enhance your patients’ cardiac health one scan at a time. Register for MyoStrain training here: myocardialsolutions.com/medical-affair…

Congratulations to our incredible speakers who led a panel discussion at #GCOS2023 this weekend. Alexander Lyon, Susan Dent, Eliseo Vaño, and Daniel Lenihan led an engaging symposium on MyoStrain® and its impact on cardio-oncology care. We look forward to next year! International Cardio-Oncology Society

Thrilled to have been part of the #GCOS2023 summit hosted by International Cardio-Oncology Society! Myocardial Solutions was proud to sponsor and engage with thought leaders - sharing insights on how MyoStrain is revolutionizing cardiac care.

According to World Health Organization (WHO)’s latest report, 76 million lives could be saved by 2050 if we effectively manage hypertension.bit.ly/3PNleQy Let's work together to empower our healthcare system to manage hypertension using MyoStrain tests.

Discover the groundbreaking potential of MyoStrain through the eyes of leading physicians. Hear how it's transforming cancer therapy monitoring and promoting cardio-protective strategies: myocardialsolutions.com/users/physicia…

This month, Dr. Daniel Lenihan highlighted MyoStrain's role in early cardiotoxicity detection at #GCOS2023. To read the PREFECT study from the panel, please visit the following page: ahajournals.org/doi/10.1161/CI…

We would like to extend our thanks to our expert panelists for highlighting MyoStrain's impact in cardio-oncology at #GCOS2023. We look forward to continuing these important conversations in the future

Traditional heart metrics fall short in evaluating individual responses to heart failure medications. MyoStrain empowers physicians with sensitivity and precision, revolutionizing treatment optimization. Learn more here: myocardialsolutions.com/applications/h…

For Breast Cancer Awareness Month, we want to call attention to a PREFECT Study that highlights MyoStrain & MyoHealth score’s potential impact on breast cancer care. Join us in advancing cancer patient care. Read here: ahajournals.org/doi/10.1161/CI…

MyoStrain technology is a game-changer for cardiology. It empowers physicians to proactively identify patients who may benefit from early cardioprotective therapy. Hear from more physicians by visiting our website: myocardialsolutions.com/users/physicia…

A recent study by UTSW reveals the hidden risks and causes of undetected hypertension. Discover how our cutting-edge MyoStrain technology could be the key to catching early damage and dysfunction. Read the article here: medicalxpress.com/news/2023-11-b…

This COPD Month, Myocardial Solutions is committed to advancing cardiovascular health and early disease detection with our MyoStrain test. Together we can work to improve the heart and lung health of patients worldwide. #COPDmonth #COPDAwareness